These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3885020)

  • 21. The effect of quercetin on the mutagenicity of 2-acetylaminofluorene and benzo[alpha]pyrene in Salmonella typhimurium strains.
    Ogawa S; Hirayama T; Nohara M; Tokuda M; Hirai K; Fukui S
    Mutat Res; 1985 Mar; 142(3):103-7. PubMed ID: 3919287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotransformation of genotoxic agents in marine sponges. Mechanisms and modulation.
    De Flora S; Bagnasco M; Bennicelli C; Camoirano A; Bojnemirski A; Kurelec B
    Mutagenesis; 1995 Jul; 10(4):357-64. PubMed ID: 7476273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of benzo[a]pyrene and 2-aminoanthracene to bacteria mutagens by mussel digestive gland postmitochondrial fraction.
    Michel XR; Cassand PM; Narbonne JF
    Mutat Res; 1993 Feb; 301(2):113-9. PubMed ID: 7678168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation and detoxication of promutagens by toadfish (Opsanus tau) hepatic postmitochondrial fractions in the Salmonella assay.
    Milling DM; Maddock MB
    Mutat Res; 1986 Apr; 164(2):81-9. PubMed ID: 3515163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of the potency of promutagens and direct acting mutagens in bacteria by inhibitors of the multidrug resistance mechanism.
    De Flora S; Camoirano A; Cartiglia C; Ferguson L
    Mutagenesis; 1997 Nov; 12(6):431-5. PubMed ID: 9412996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-mutagenic activity of Phyllanthus amarus Schum & Thonn in vitro as well as in vivo.
    Raphael KR; Ajith TA; Joseph S; Kuttan R
    Teratog Carcinog Mutagen; 2002; 22(4):285-91. PubMed ID: 12111712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vitamins A, C and glutathione on the mutagenicity of benzo[a]pyrene mediated by S9 from vitamin A-deficient rats.
    Alzieu P; Cassand P; Colin C; Grolier P; Narbonne JF
    Mutat Res; 1987 Dec; 192(4):227-31. PubMed ID: 2446127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excretion of 3-hydroxy-benzo(a)pyrene and mutagenicity in rat urine after exposure to benzo(a)pyrene.
    Jongeneelen FJ; Leijdekkers CM; Bos RP; Theuws JL; Henderson PT
    J Appl Toxicol; 1985 Oct; 5(5):277-82. PubMed ID: 3902943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenicity of pyrene in Salmonella.
    Matijasević Z; Zeiger E
    Mutat Res; 1985 Apr; 142(4):149-52. PubMed ID: 3885017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenic activation of aromatic amines by a human hepatoma cell (Hep G2) supernatant tested by means of Salmonella typhimurium strains with different acetyltransferase activities.
    Duverger-van Bogaert M; Dierickx PJ; Crutzen MC
    Mutat Res; 1995 Dec; 335(3):219-27. PubMed ID: 8524336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of age on the ability of rat liver tissues to transform chemical promutagens to mutagens.
    Hilali A; Crutzen-Fayt MC; Gerber GB; Léonard A
    Gerontology; 1993; 39(3):125-7. PubMed ID: 8406054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential pitfalls associated with testing of enzyme preparations in the Salmonella/microsome assay.
    Conti L; Crebelli R
    Regul Toxicol Pharmacol; 2016 Oct; 80():291-4. PubMed ID: 27330008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of promutagens by liver homogenates isolated from female mice at different ages; lack of significant differences.
    Guttenplan JB; Bliznakov EG
    Mech Ageing Dev; 1981 May; 16(1):29-35. PubMed ID: 6265715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds.
    De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A
    Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of some aromatic amines to mutagenic products by human red blood cell cytosol.
    Duverger-van Bogaert M; Crutzen-Fayt MC; Stecca C
    Mutat Res; 1991 Aug; 263(4):249-55. PubMed ID: 1861690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimum S9 concentrations in bacterial mutagenicity assays.
    Forster R; Green MH; Priestley A
    Adv Exp Med Biol; 1981; 136 Pt B():1263-9. PubMed ID: 7046386
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of Aroclor 1254 dose upon S9 activation of aromatic amine bacterial mutagens.
    Thompson CZ; Whitaker GW; McMahon RE
    Mutat Res; 1980 Apr; 77(4):361-6. PubMed ID: 6769038
    [No Abstract]   [Full Text] [Related]  

  • 38. Reversal of sodium-azide mutagenicity by liver preparations and by gastric juice.
    de Flora S; Coppola R; Zanacchi P; Bennicelli C
    Mutat Res; 1979 Jul; 61(2):387-92. PubMed ID: 384225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism and mutagenicity of aromatic amines by human fetal liver.
    Aune T; Haugen A; Dybing E
    Arch Toxicol; 1985 Jun; 57(2):136-8. PubMed ID: 4026573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutagenicity of methylated fluorenes and benzofluorenes.
    Lavoie EJ; Tulley L; Bedenko V; Hoffmann D
    Mutat Res; 1981 May; 91(3):167-76. PubMed ID: 7017394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.